C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/13 (2006.01) A61K 39/395 (2006.01) C07K 16/12 (2006.01) C07K 16/42 (2006.01) C12N 5/12 (2006.01)
Patent
CA 2482747
The present invention relates to an anti-idiotype antibodies directed against the monoclonal antibody (HmenB3) to Neisseria meningitidis serogroup B and hybridomas producing the anti-idiotype antibodies. This invention is also directed to vaccine compositions comprising the anti-idiotypic antibodies in combination with pharmaceutically acceptable carriers. These vaccine compositions can be used to prevent or treat the serogroup B meningococcal disease.
L'invention concerne des anticorps anti-idiotypes dirigés contre l'anticorps monoclonal (HmenB3), le sérogroupe B de <i>Neisseria meningitidis</i> et des hybridomes produisant les anticorps d'anti-idiotypes. Cette invention concerne également des compositions de vaccin comprenant les anticorps anti-idiotypes en combinaison avec des excipients acceptables sur le plan pharmaceutique. Ces compositions de vaccin peuvent être utilisées en vue de prévenir ou de traiter la méningoccocie de sérogroupe B.
Choi In-Hong
Nahm Moon H.
Park In-Ho
Shin Jeon-Soo
Bereskin & Parr Llp/s.e.n.c.r.l.,s.r.l.
Yonsei University
LandOfFree
Vaccine composition for preventing meningococcal disease does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Vaccine composition for preventing meningococcal disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vaccine composition for preventing meningococcal disease will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2021709